Showing results (2041-2050 of 4,509) with videos related to
Sort By:
Pageof 451
Journal of Human Hypertension|May 26, 2017
The effect of high altitude on central blood pressure and arterial stiffnessC J Boos, E Vincent, A Mellor, et al.Journal of Human Hypertension|June 1, 1987
Severe hypertension with absent secondary sex characteristics due to partial deficiency of steroid 17 alpha-hydroxylase activityR Fraser, J J Brown, P A Mason, et al.Journal of Human Hypertension|August 1, 1988
Platelet-activating factor and anti-platelet-aggregating factor in acute reduction of blood pressure following percutaneous transluminal renal angioplasty in patients with renovascular hypertensionF Masugi, T Ogihara, S Saeki, et al.Journal of Human Hypertension|June 8, 2017
Adiposity and blood pressure among 55 000 relatively lean rural adults in southwest of ChinaX Chen, H Du, J Zhang, et al.Journal of Human Hypertension|April 23, 2002
Effect of angiotensin II on pulse wave velocity in humans is mediated through angiotensin II type 1 (AT(1)) receptorsA Rehman, A R A Rahman, A H G RasoolJournal of Human Hypertension|March 1, 1988
Interaction in hypertensive man between sodium intake, converting enzyme inhibitor (enalapril), plasma renin and blood pressure controlT Morgan, A AndersonJournal of Human Hypertension|July 12, 2018
Impact of SPRINT results on hypertension guidelines: implications for "frail" elderly patientsGennaro Russo, Ilaria Liguori, Luisa Aran, et al.Journal of Human Hypertension|June 1, 1992
First dose hypotension after captopril; can it be predicted? A study of 240 patientsC T Postma, P J Dennesen, T de Boo, et al.Journal of Human Hypertension|May 1, 1997
Serum angiotensin-converting enzyme activity correlates positively with plasma angiotensin II: a population-based study of ambulatory blood pressure and the renin-angiotensin systemF Nyström, B E Karlberg, K P OhmanJournal of Human Hypertension|May 1, 1997
The effects of atenolol and zofenopril on plasma atrial natriuretic peptide are due to their interactions with target organ damage of essential hypertensive patientsF Elijovich, C L Laffer, E L SchiffrinPageof 451